Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now

Tetra Tech (TTEK) Surges 54% YTD: What's Driving The Stock?

Published 08/28/2019, 09:34 PM
Updated 07/09/2023, 06:31 AM

Tetra Tech, Inc.’s (NASDAQ:TTEK) price performance has been impressive so far in 2019, with shares having gained 55.3%. Solid financial performances and future growth opportunities have supported positive market sentiments for this stock.

The California-based company belongs to the Zacks Pollution Control industry. It currently carries a Zacks Rank #2 (Buy) and has a favorable VGM Score of B. Earnings in the next five years are predicted to rise 15.5%.

You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Year to date, Tetra Tech has outshined its industry’s growth of 24.7%, the Zacks Industrial Products sector’s rally of 4% and the S&P 500’s improvement of 13%.




It is worth mentioning here that Tetra Tech has reported better-than-expected results for three quarters in a row so far in 2019. Average positive earnings beat for these three quarters (or the first three quarters of fiscal 2019, ending September) was 11.2%. Notably, earnings in the last reported quarter surpassed estimates by 11.25%.

Factors Driving the Stock

We believe that broader factors are playing role in Tetra Tech’s success. Pollution-related risks, stringent government regulations, and increasing demand in emerging nations are benefiting the industry players. Such tailwinds have placed the industry in top 37% (with the rank of 94) of more than 250 Zacks industries. Also, the industry’s current growth estimates for earnings is 13.27%, higher than the S&P 500’s 9.03%.

Narrowing down on company-specific factors, contract wins have played a vital role. Of late, the company has been awarded $132 million from U.S. Environmental Protection Agency, $70-million contract from the U.S. Agency for International Development and $46 million from the U.S. Army Corps of Engineers, Transatlantic Middle East District, among other contracts.

In addition, growing demand for disaster response and recovery planning as well as the broad-based infrastructure business has been aiding Tetra Tech. Also, services required for environmental programs, industrial water treatment, renewable energy and high-performance buildings have strengthened revenues.

Acquisitive nature of Tetra Tech has been boosting growth opportunities as well. The buyout of eGlobalTech in April 2019 has been strengthening the company’s business from commercial and government customers. Also, it added WYG plc — a provider of engineering and consulting services — to its portfolio in July. WYG is anticipated to enhance Tetra Tech’s businesses in the U.K. and Europe as well as in environment, water and infrastructure markets. Shareholder-friendly policies raised the stock’s attractiveness. Dividend payments and stock buybacks are popular ways of boosting stakeholders’ wealth.

Earnings estimates for the company have been raised in the past 60 days, reflecting positive sentiments about its growth prospects. Earnings estimates for the current year and the next year have grown 1.6% and 2.1% from the respective 60-day-ago figures.

Tetra Tech, Inc. Price and Consensus

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Tetra Tech, Inc. price-consensus-chart | Tetra Tech, Inc. Quote

Tetra Tech’s Performance Versus Three Peers

Tetra Tech has outperformed many industry peers so far in 2019. Three such stocks are CECO Environmental Corp. (NASDAQ:CECE) , Donaldson Company, Inc. (NYSE:DCI) and Energy Recovery, Inc. (NASDAQ:ERII) , with respective year-to-date gains of 1.9%, 7.9% and 36%.

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>



Energy Recovery, Inc. (ERII): Free Stock Analysis Report

Donaldson Company, Inc. (DCI): Free Stock Analysis Report

Tetra Tech, Inc. (TTEK): Free Stock Analysis Report

CECO Environmental Corp. (CECE): Free Stock Analysis Report

Original post

Zacks Investment Research

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.